Citation Tools

Download PDFPDF
Randomised controlled trial
Exenatide may improve maintenance of HbA1c targets, with less hypoglycaemia, but more early adverse effects when compared with low-dose glimepiride

Download to a citation manager

Cite this article as:
Campbell-Scherer DL, Johnson JA
Exenatide may improve maintenance of HbA1c targets, with less hypoglycaemia, but more early adverse effects when compared with low-dose glimepiride